Biomarker Discovery, Validation, and CLIA Testing

  • Home
  • Biomarker Discovery, Validation, and CLIA Testing

Biomarker Discovery, Validation & CLIA Testing

Empowering Precision Medicine Through Biomarker-Driven Innovation

At Axela Biosciences, we are dedicated to advancing precision diagnostics and personalized therapies through comprehensive biomarker solutions. As a CLIA-certified laboratory, we support biopharma and medical device companies with high-impact services spanning the full biomarker lifecycle—from discovery and validation to CLIA testing and clinical implementation.

Comprehensive Diagnostic Services

Biomarker Discovery & Validation

Leveraging cutting-edge genomics, proteomics, and metabolomics, we identify and validate novel biomarkers that enhance disease diagnosis, prognosis, treatment response, and patient stratification. Our discovery and validation workflows are designed to accelerate clinical development and inform therapeutic strategy.

Lab Developed Tests (LDTs)

We design, develop, and validate custom LDTs for a wide range of indications. With a focus on analytical performance and clinical relevance, our LDTs are optimized for use in both exploratory and regulated clinical environments.

CLIA-certified Lab Multi-Platform Biomarker Analysis
  • Flow Cytometry
  • Multiplex Immunoassays
  • High-throughput Genomic & Proteomic Technologies
  • These robust platforms ensure reliable data for accurate patient selection, efficacy monitoring, and clinical decision-making.
Companion Diagnostics (cDx)

In partnership with biopharma companies, we co-develop and commercialize companion diagnostics to guide patient enrollment and enhance therapeutic efficacy. Our capabilities include IHC-based assays, molecular diagnostics, and other platforms tailored to your drug development program.

Sponsored Testing Programs

Axela collaborates with clinical and industry partners to implement sponsored biomarker testing programs, enabling targeted recruitment and optimized therapy access. These programs are instrumental in driving successful trials and informed treatment strategies.